| abstract |
Compounds of general formula (I), or their stereoisomers, tautomers, pharmaceutically acceptable salts, or prodrugs (where R1, R2, R3, R4, R5, R6, R8 and R9) Are as defined herein) are useful in the treatment of diseases and conditions mediated by excessive or inappropriate Hsp90, such as cancer, viral infections and inflammatory diseases or conditions. |